EX-10.4
from 10-Q
7 pages
Now Therefore, in Consideration of the Premises and Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Parties Hereto Hereby Agree as Follows: 1. Definitions. All Terms Used Herein That Are Defined in the Financing Agreement and Not Otherwise Defined Herein Shall Have the Meanings Assigned to Them in the Financing Agreement. 2. Amendments. (A) New Definitions. Section 1.01 of the Financing Agreement Is Hereby Amended by Adding the Following Definitions, in Appropriate Alphabetical Order: (I) ““Amendment No. 6” Means Amendment No. 6 to Financing Agreement, Dated as of November 8, 2020, by and Among the Loan Parties, the Administrative Agent and the Lenders.” (II) ““Amendment No. 6 Effective Date” Means the “Amendment Effective Date” as Set Forth in Amendment No. 6.” (B) Section 6.8(a) (Minimum Qualified Cash). Section 6.8(a) of the Financing Agreement Is Hereby Amended and Restated in Its Entirety to Read as Follows
12/34/56
EX-10.2
from 10-Q
151 pages
Credit and Security Agreement Dated as of May 1, 2018 by and Among Therapeuticsmd, Inc., Its Subsidiaries From Time to Time Party Hereto, Each as Borrower, and Collectively as Borrowers, and Midcap Financial Trust, as Agent and as a Lender, and the Additional Lenders From Time to Time Party Hereto
12/34/56
